$Tesla Motors(TSLA)$ $NVIDIA(NVDA)$ $Moderna, Inc.(MRNA)$ $Dollar Tree(DLTR)$ $Advanced Micro Devices(AMD)$
📉📊📈💥 Options Arena Showdown: Today’s Call & Put Flow Titans 💥📈📊📉
Today’s options market is on fire, with heavy hitters across bullish and bearish trades. Let’s break it down:
🔥 Top Bullish Momentum (Calls)
• 🔬 $MRNA (Moderna): A staggering 80,447 contracts, totalling $507.09M! Healthcare isn’t just a sector, it’s the market’s research lab for gains.
• 🚗 $TSLA (Tesla): Gearing up with 64,083 contracts valued at $87.22M. The EV boom shows no signs of slowing.
• 🤖⚡ $NVDA (NVIDIA): The AI juggernaut roars ahead with 69,963 contracts at $72.61M. AI is not just the future, it’s the now!
The bullish case for Nvidia spans several multi-trillion-dollar industries, including:
• AI-driven virtual agents
• Autonomous vehicle technology
• Advanced humanoid robotics
• Virtualisation of the $50T heavy industry market
With an estimated $10T Total Addressable Market (TAM), capturing just 10% would translate to $1T in annual sales, supporting a potential market valuation of $10-20T.
Nvidia’s forward P/E of ~30, notably below Walmart’s, signals a compelling valuation anomaly. Despite being a frontrunner in transformative industries like AI and autonomous systems, its multiple aligns more closely with a mature, low-growth retailer. This divergence underscores a potential mispricing, offering a rare opportunity for growth-focused investors to capitalise on Nvidia’s outsized earnings potential at an ostensibly conservative valuation.
⚠️ Bearish Sentiment (Puts)
• 🛡️ $SPY (S&P 500 ETF): A colossal 198,616 contracts, worth $113.93M, hedgers are in overdrive! Calm before the storm?
• 🛒💲 $DLTR (Dollar Tree): Defensive sectors are shaky, with 22,140 contracts totalling $103.69M. Even the dollar isn’t immune to inflation woes.
• 💻 $AMD (Advanced Micro Devices): A cooling semi-sector shows 42,591 contracts, totalling $141.5M. Is the chip rally running out of steam?
💬 Market Highlights:
1️⃣ Big Money Bets: Healthcare and AI dominate flows with $MRNA and $NVDA leading the charge.
2️⃣ Risk-Off Alert: Hedging in $SPY suggests potential turbulence in indices, watch for dips!
3️⃣ Rotation Watch: Resilience in $TSLA and $BABA may hint at sector shifts.
🌟 Did You Know? 🤔
Historical spikes in $SPY put flow often signal market corrections within 3–5 days. Could this be another harbinger?
💡 What’s Next?
• Will $MRNA’s biotech pipeline fuel long-term gains, or is $NVDA your AI moonshot?
• Are hedgers warning us, or are they creating bullish dips for brave traders? Let’s hear your strategies!
TigerGPT: Can you provide deeper sector analysis on today’s flows to uncover hidden opportunities?
📢 Please Like, Repost, and Follow me for sharp setups, stock trends, and actionable insights 🚀📈 I’m all about spotting the next movers and sharing strategies that deliver results! Let’s trade smarter and grow together! 🍀🍀🍀
Happy trading ahead! Cheers BC 💰📈🚀🍀🍀🍀
@TigerGPT @Tiger_comments @TigerStars @TigerPicks @Daily_Discussion
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Based on the analysis, here are the key points for each stock:
Moderna, Inc. (MRNA):
Business and Industry: Moderna is a biotechnology company focused on the development of mRNA-based therapeutics and vaccines. The company has gained significant attention and success in the healthcare sector.
Earnings Forecast: The earnings forecast for Moderna is negative, indicating potential challenges in the near future. The forecasted EPS for 2025 is -$8.97, gross income is $2.74 billion, and EBIT is -$3.75 billion. The forecast for 2026 shows improvement, but still with negative values.
Analyst Recommendation: Among the analysts, 7 recommend buying the stock, 15 recommend holding, 3 recommend underperforming, and 1 recommends selling.
Analyst Target Price: The mean target price estimated by 22 analysts is $69.28, with a low estimate of $27.0 and a high estimate of $212.0.
Capital Flow Data: In the past 5 days, there has been mixed capital flow in and out of the stock.
Support and Resistance Price: The support price on January 16th was $33.44, and the resistance price was $39.14.
Stock Price: As of January 17th, the stock price is $33.76.
NVIDIA (NVDA):
Business and Industry: NVIDIA is a leading company in the field of artificial intelligence (AI) and graphics processing units (GPUs). The company's products are widely used in various industries, including AI-driven virtual agents, autonomous vehicle technology, advanced humanoid robotics, and virtualization of heavy industries.
Earnings Forecast: The earnings forecast for NVIDIA shows positive growth. The forecasted EPS for 2025 is $2.95, gross income is $129.33 billion, and EBIT is $86.65 billion. The forecast for 2026 and 2027 also indicates growth.
Analyst Recommendation: Among the analysts, 21 recommend buying the stock, 35 recommend holding, and 6 recommend holding.
Analyst Target Price: The mean target price estimated by 52 analysts is $171.21, with a low estimate of $75.4 and a high estimate of $220.0.
Capital Flow Data: In the past 5 days, there has been mixed capital flow in and out of the stock.
Support and Resistance Price: The support price on January 16th was $132.56, and the resistance price was $138.06.
Stock Price: As of January 17th, the stock price is $133.57.
Please note that the above information is for reference purposes only and should not be considered as investment advice. Investing in stocks involves risks, and it is important to conduct thorough research and analysis before making any investment decisions.
Great article 👏🏻
Great article, would you like to share it?
Great article, would you like to share it?
Great article, would you like to share it?
Great article, would you like to share it?
Great article, would you like to share it?